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ABSTRACT
Vasopressin regulates water reabsorption in the collecting duct, but extracellular nucleotides modulate
this regulation through incompletely understood mechanisms. We investigated these mechanisms using
immortalized mouse collecting duct (mpkCCD) cells. Basolateral exposure to dDAVP induced AQP2
localization to the apical membrane, but co-treatment with ATP internalized AQP2. Because plasma
membrane-bound P2 receptors (P2R) mediate the effects of extracellular nucleotides, we examined the
abundance and localization of P2R in mpkCCD cells. In the absence of dDAVP, P2Y1 and P2Y4 receptors
localized to the apical membrane, whereas P2X2, P2X4, P2X5, P2X7, P2Y2, P2Y11, and P2Y12 receptors
localized to the cytoplasm. dDAVP induced gene expression of P2X1, which localized to the apical
domain, and led to translocation of P2X2 and P2Y2 to the apical and basolateral membranes, respec-
tively. In co-expression experiments, P2R activation decreased membrane AQP2 and AQP2-mediated
water permeability in Xenopus oocytes expressing P2X2, P2Y2, or P2Y4 receptors, but not in oocytes
expressing other P2R subtypes. In summary, these data suggest that AQP2-mediated water transport is
downregulated not only by basolateral nucleotides, mediated by P2Y2 receptors, but also by luminal
nucleotides, mediated by P2X2 and/or P2Y4 receptors.
J Am Soc Nephrol 20: 1480–1490, 2009. doi: 10.1681/ASN.2008070686
Urinary concentration and water homeostasis are
primarily under the control of arginine vasopressin
(AVP) acting on the renal collecting duct (CD).
AVP ultimately exerts its effect by controlling the
abundance of aquaporin 2 (AQP2) water chan-
nels in the apical membrane of CD principal cells
(PCs): it activates V2 receptors in the basolateral
membrane of these cells and stimulates adenylyl
cyclase (increasing intracellular cAMP levels),
which in turn results in phosphorylation of AQP2
and its rapid (within minutes) trafficking and in-
sertion into the apical membrane (from subapi-
cal storage vesicles),1,2 together with reduced en-
docytosis of AQP2;3 continued exposure to AVP
over several days stimulates AQP2 gene tran-
scription.4,5
Increased apical abundance of AQP2 enhances
water reabsorption and produces a concentrated
urine; in the absence of AVP, AQP2 is internalized
by ubiquitin-dependent endocytosis,6 leading to re-
ducedwater reabsorption and a dilute urine. There-
fore, any dysregulation of AQP2 synthesis or sur-
Received July 7, 2008. Accepted February 9, 2009.
Published online ahead of print. Publication date available at
www.jasn.org.
Ccorrespondence: Dr. Scott S. P. Wildman, Urinary System Phys-
iology Unit, Department of Veterinary Basic Sciences, Royal Vet-
erinary College, Camden Campus, Royal College Street, London
NW1 0TU, United Kingdom. Phone: 44 (0)20 7121 1903; Fax:
44 (0)20 7468 5204; E-mail: swildman@rvc.ac.uk
Copyright  2009 by the American Society of Nephrology
BASIC RESEARCH www.jasn.org
1480 ISSN : 1046-6673/2007-1480 J Am Soc Nephrol 20: 1480–1490, 2009
face membrane abundance will affect fluid balance: lack of
normal AQP2 abundance or function in cranial or nephro-
genic diabetes insipidus causes excessive water loss and hyper-
natremia,7,8,9 while increased apical membrane abundance of
AQP2 in congestive heart failure, liver cirrhosis, or the syn-
drome of inappropriate ADH secretion causes enhanced water
retention and hyponatremia.10,11
Several paracrine or autocrine factors, including extracellular
nucleotides, have been shown to inhibit AVP-stimulated and
AQP2-mediated water transport in the CD.12–20 The effect of ex-
tracellular nucleotides is mediated by activation of plasmamem-
brane-bound P2 receptors (P2R) in CD PCs. The presence of al-
most all of the molecularly identified subtypes of ionotropic
(P2X) and metabotropic (P2Y) P2R has been demonstrated in
CDepithelial cells and immortalized distal nephron epithelial cell
lines.21–24 Ionotropic P2X receptors are represented by homo-
meric assemblies (P2X1, P2X2, P2X3, P2X4, P2X5, P2X6, and
P2X7) and heteromeric assemblies (P2X1/2, P2X1/4, P2X1/5,
P2X2/3, P2X2/6, P2X4/6, and P2X4/7).25 Metabotropic P2Y recep-
tors are representedbyP2Y1, P2Y2, P2Y4, P2Y6, P2Y11, andP2Y12,
and the recently cloned P2Y13 and P2Y14, subtypes.25
Based on pharmacologic profiling (although it should be
noted that truly specific agonists are not available for P2R), the
P2R subtype thought to inhibit AVP-stimulated water trans-
port in the CD is the P2Y2 receptor present in the basolateral
membrane of PCs.12,15 This P2R-mediated inhibition is PKC-
dependent, and the result of decreased intracellular cAMP and
increased PGE2 levels.26,27 In support of a role for the P2Y2 recep-
tor inmodulatingAVP-mediated changes inCDwater transport,
infusion of AVP (for 90 min) increases P2Y2 mRNA and protein
levels in theCDofhydratedrats.28Therefore, ithasbeenproposed
that activation of basolaterally located P2Y2 receptors by extracel-
lular nucleotides significantly affects AQP2 abundance, and
thereby AVP-mediated water reabsorption, in the CD.29 Indeed,
P2Y2knockoutmiceexhibithigher levelsofAQP2comparedwith
wild-type mice, despite similar AVP levels.30,31
Activation of basolaterally localized P2Y2 receptors has also
been linked to the local control of amiloride-sensitive Na
reabsorption in CD PCs,22 an effect that also occurs with lumi-
nal (apical) ATP. However, we have recently shown that the
P2Y2 subtype is not the only P2R tomediate a luminal effect of
ATP on CDNa transport.24 Combining molecular and phar-
macologic approaches, we found that activation of P2Y4
(which is almost identical in its pharmacologic profile to
P2Y2), P2X4, or P2X4/6 receptors can also affect Na
 transport.
Furthermore, we showed that changing dietary Na intake al-
ters P2R mRNA and protein levels.24
Two questions arise from the previously published work:
(1) Can AVP alter the protein abundance and mRNA levels of
P2R other than the P2Y2 subtype? (2) Can P2R other than the
P2Y2 subtype affect AVP-stimulated AQP2 abundance in CD
PCs? In the present study, we have used immortalized mouse
mpkCCD(c14) cells and the Xenopus oocyte heterologous ex-
pression system to clarify the molecular interactions between
P2R subtypes and AQP2 abundance, and internalization.
RESULTS
Immunocytochemical Localization of AQP2 in mpkCCD
Cells
To determine whether AVP induces plasma membrane local-
ization of AQP2 in mpkCCD cells, monolayers of these cells
were either left untreated or were treated with dDAVP. In the
absence of dDAVP (n  12), no immunofluorescent staining
for AQP2 was detectable in the cells or their apical membranes
(Figure 1A); however, treatmentwith dDAVP (1nMapplied to
the basolateral medium for 96 h; n  12) resulted in strongly
positive immunofluorescence for AQP2 in the apical mem-
brane (Figure 1B). Thus, as in earlier published studies,32,33
Figure 1. dDAVP-induced localization of AQP2 in mpkCCD cells.
Confocal microscopy was used to visualize the cellular distribution
of AQP2 in monolayers of mpkCCD cells grown to confluence on
transwell permeable supports in the absence or presence of 1 nM
dDAVP (applied to the basolateral medium) for 96 h. Images
shown are x-y planes (large rectangle) and x-z planes (shown
beneath the x-y plane). Monolayers were imaged in x-z planes
from apical to basal boundaries of the cells. The x-z image is from
the site indicated by the dashed line. (A) In cells untreated with
dDAVP, immunostaining for AQP2 was not evident. (B) Treatment
of cells with dDAVP resulted in positive immunostaining (FITC) for
AQP2 in the apical domain. Scale bar represents 5 m.
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treatment with dDAVP for 96 h is sufficient to induce endog-
enous AQP2 synthesis and apical localization.
mRNA Levels of P2R in mpkCCD Cells
To investigate the relative abundance of P2RmRNA inmono-
layers of cells treated or untreated with dDAVP, we performed
real-time PCR analysis and calculated the ratio of expression of
the P2R gene of interest to a constitutively expressed house-
keeping gene (hypoxanthine phosphoribosyl transferase
[HPRT]). In untreated cells, we could not detect significant
levels of P2X1, P2X3, or P2X6 subunit mRNA, or of P2Y6 re-
ceptor mRNA (n 6; Figure 2,A and B, respectively). In con-
trast, significant amounts of mRNA were detected for P2X2,
P2X4, P2X5, and P2X7 subunits (Figure 2A), and for P2Y1,
P2Y2, andP2Y4 receptors (Figure 2B);mRNAabundance had a
rank order of P2Y2P2X2  P2X4  P2Y1  P2Y4P2X5 
P2X7.
Cells treated with dDAVP showed a significant increase in
abundance of P2Y2 mRNA (by 7-fold; n  6; P  0.01), a
significant decrease in abundance of P2Y1mRNA (by 2.5-fold;
n 6; P 0.01), but no change in P2X2, P2X4, P2X5, P2X7, or
P2Y4 mRNA levels (Figure 2, A and B). P2X1 mRNA levels
increased significantly in cells treated with dDAVP (Figure
2A). Rank order of abundance for P2R mRNA in cells treated
with dDAVP was P2Y2P2X1  P2X4P2X2  P2Y1 
P2Y4 P2X5 P2X7.
These data suggest that mpkCCD cells express a variety of
P2R and that chronic dDAVP treatment alters the mRNA lev-
els of several P2R subtypes.
Localization of P2R in mpkCCD Cells
To investigate P2R protein localization in untreated mpkCCD
cells, monolayers of cells (n 6) were stained for different P2R
using specific antibodies. Positive immunofluorescence for
P2Y1 and P2Y4 receptors was seen apically, whereas P2X2,
P2X4, P2X5, and P2X7 receptor subunits and P2Y2, P2Y11, and
P2Y12 receptors were located throughout the cytoplasm, to-
ward the cell borders and in the perinuclear region (Figure 3A).
Immunofluorescent staining for P2X1, P2X3, and P2X6 sub-
units and the P2Y6 receptor was not seen. These data broadly
agree with the real-time PCR findings.
To corroborate the apical localization of P2Y1 and P2Y4
receptors in cells untreatedwith dDAVP,whole-cell perforated
patch-clamp recordings were made on individual cells using
P2R-selective agonists. Figure 3B shows ATP- and other P2R
agonist-evoked (all at 10 M) whole-cell inward currents in
voltage-clamped (holding potential [Vh]60mV) cells in a
confluent monolayer. Agonists were chosen according to their
P2R selectivity (see Table 1).24,34 The amplitudes of 10 M
agonist-evoked currents were 584  59 pA (for ATP; n  5),
540 48 pA (for UTP; n 5), 226 26 pA (for ADP; n 5),
29 11 pA (for BzATP; n 5), 343 29 pA (for ATPS; n
5), and 234  40 pA (for 2meSADP; n  5); consistent with
apical P2Y1 and P2Y4 receptor localization.
To test whether dDAVP alters the abundance and/or local-
ization of P2R, mpkCCD cells were treated with dDAVP and
subjected to immunocytochemistry using P2R-specific anti-
bodies. Treatment with dDAVP (1 nM; 96 h; basolateral me-
dium) resulted in positive immunostaining for P2X1 and P2X2
receptor subunits in the apical regions, and basolateral staining
for P2Y2 receptors (Figure 4,A and B), suggesting that dDAVP
induces the synthesis of P2X1, and targets P2X1, and P2X2 re-
ceptor subunits, as well as P2Y2 receptors, to the plasmamem-
brane. Fluorescence immunostaining for all other P2R re-
mained unchanged (data not shown).
To investigate whether dDAVP-dependent P2R synthesis
and localization is cAMP-dependent, dDAVP-treated mp-
kCCDcells were incubatedwith the cell-permeable PKA inhib-
Figure 2. Effect of dDAVP on P2R mRNA levels in mpkCCD cells. Real-time PCR was used to compare P2X and P2Y receptor mRNA
levels in monolayers of mpkCCD cells grown to confluence on transwell permeable supports maintained in either the absence or
presence of 1 nM dDAVP (applied to the basolateral medium) for 96 h. The data are presented as a ratio of the P2R gene of interest
to the constitutively expressed housekeeping gene HPRT. (A) Following dDAVP treatment, mRNA levels for P2X1 subunits were
significantly increased (n  6; P  0.01). (B) Following dDAVP treatment, mRNA levels for P2Y1 receptors were significantly decreased
(n  6; P  0.01), and mRNA levels for P2Y2 receptors were increased (n  6; P  0.01).
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itor H-89 and subjected to immunocytochemistry using
P2X1-, P2X2-, and P2Y2-specific antibodies. Treatment with
H-89 (1 M; 30 min; basolateral medium) abolished dDAVP-
dependent P2X1 synthesis (and apical localization), dDAVP-
dependent P2X2 apical localization, and dDAVP-dependent
P2Y2 basolateral localization (data not shown), strongly sug-
gesting that dDAVP-dependent P2R synthesis and localization
in mpkCCD cells is cAMP-dependent. In the absence of
dDAVP, H-89 failed to alter fluorescence immunostaining for
any P2R.
Acute Effects of P2R Activation on AQP2 Membrane
Localization in mpkCCD Cells
To investigate the effect of ATP on AQP2 localization,
dDAVP-treated mpkCCD cell monolayers were treated with 1
M ATPS (a stable analog of ATP with agonist activity at
most P2R) for 2 h, added to either the apical or basolateral
medium (n  5). Immunostaining revealed that whereas
AQP2 was localized to the apical membrane in the absence of
ATPS, it was present intracellularly following exposure to
ATPS in either the apical or basolateral medium (Figure 5A),
consistent with AQP2 internalization.
To confirm that ATP itself causes internalization of AQP2,
ATP was added to both apical and basolateral medium of cul-
tured mpkCCD cells or to each medium separately for 2 h.
Subsequent cell surface biotinylation, and semiquantification
of AQP2 abundance by immunoblotting, showed that AQP2
was internalized from the plasma membrane when ATP was
added to either the apical or basolateral medium (Figure 5, B
and C), and that this effect was increased when ATPwas added
to both medium (Figure 5, B and C). These data indicate that
both apical and basolateral P2R can affect apical membrane
abundance of AQP2, and that the effect is additive.
To investigate which of the apically localized P2R (P2X1,
P2X2, P2Y1 and/or P2Y4; see Figures 3, A and B, and 4) causes
internalization of AQP2, a selection of partially selective P2R
agonists was added to the apicalmediumof culturedmpkCCD
cells for 2 h. Subsequent cell surface biotinylation, and semi-
quantification of AQP2 abundance by immunoblotting,
showed that AQP2 was internalized from the plasma mem-
brane when ATP (100M; a potent agonist at P2X1, P2X2, and
P2Y4 receptor subtypes) or UTP (100 M; an agonist selec-
tively favoring the P2Y4 receptor subtype), but not 2meSADP
(100 M; an agonist selective for the P2Y1 receptor subtype),
was added (Figure 5D). AQP2 membrane abundance was re-
duced to a greater extent by ATP than by UTP. These data
indicate that apical P2Y4 receptors and P2X1 and/or P2X2 re-
ceptors, but not P2Y1, play an important role in altering AQP2
abundance and localization.
Longer-term Effects of P2R activation on AQP2 Levels
in mpkCCD Cells
To test whether P2R activation results in AQP2 protein degra-
dation, dDAVP-treated mpkCCD cells were incubated with
ATP (100M) added to both sides (apical and basolateral) for
8 h. Subsequent immunoblotting for AQP2 and ß-actin (to
normalize for the amount of protein loaded) indicated that
Table 1. Pharmacologic profiles of those P2R subtypes identified in the apical membrane of mpkCCD cells (in the
absence of dDAVP treatment; see Figure 3)
ATP UTP ADP BzATP ATPS 2meSADP
P2Y1 agonist i.a. agonist i.a. agonist agonist
P2Y4 agonist agonist i.a. antagonist agonist
(partial)
i.a.
Information taken from King and Townsend-Nicholson, 2003; Wildman et al, 2008.24,34 i.a., inactive agonist at 10 M.
Figure 3. P2R localization in mpkCCD cells. Confocal microscopy
was used to determine the cellular distribution of P2R in monolayers
of mpkCCD cells grown to confluence on transwell permeable sup-
ports (maintained for 96 h in the absence of dDAVP). Images shown
are x-z planes. Monolayers were imaged in x-z planes from apical to
basal boundaries of the cells. Scale bar represents 5 m. (A) Positive
immunostaining (CY3) for P2Y1 and P2Y4 receptors was seen in the
apical region, whereas P2X2, P2X4, P2X5, and P2X7 receptor sub-
units, and P2Y2, P2Y11, and P2Y12 receptors, were located through-
out the cytoplasm extending up to the cell border. (B) Typical trace
showing a series of P2R agonist-evoked (10 M) inward currents
from a whole-cell nystatin-permeabilized patch-clamped mpkC-
CD(c14) cell in a confluent monolayer (grown on a glass coverslip
and maintained for 96 h in the absence of dDAVP). The cell was
voltage-clamped at 60 mV, and there was 5 min interval between
agonist applications. P2R agonists ATP, UTP, ADP, ATPS, and
2meSADP evoked inward currents consistent with apical P2Y1 and
P2Y4 activation.
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ATP treatment reduced AQP2 protein levels by approximately
90% (Figure 6,A and B).
To investigate whether adenosine, derived from the break-
down of ATP, could be responsible for the ATP-evoked reduc-
tion in AQP2 membrane abundance, dDAVP-treated cells
were incubated with ATP (100 M) and DPCPX (10 M; a
nonselective adenosine, P1, receptor antagonist) added to both
sides for 8 h. Subsequent immunoblotting for AQP2 demon-
strated that simultaneous treatment with ATP and DPCPX
also markedly reduced AQP2 protein levels (Figure 6, C and
D). Furthermore, dDAVP-treated cells were incubated with
ATPS (100M; a stable analog of ATPwith agonist activity at
most P2R) added to both sides for 8 h; subsequent immuno-
blotting for AQP2 demonstrated that ATPS reduced AQP2
Figure 5. Effect of ATP on localization and
membrane abundance of AQP2 in mpkCCD
cells. (A) Confocal microscopy was used to
determine the cellular distribution of AQP2 in
monolayers of mpkCCD cells grown to con-
fluence on transwell permeable supports fol-
lowing treatment with 1 nM dDAVP (applied
to the basolateral medium) alone for 96 h, or
along with 1 M ATPS (applied to either the
apical or basolateral medium) for the final 2 h.
Monolayers were imaged in x-z planes. In
cells where ATPS was added to the apical or
basolateral medium, positive immunostaining
for AQP2 was no longer evident in the apical
domain (see top panel), but instead was
present weakly throughout the cytoplasm.
Scale bar represents 5 m. (B) Confluent mp-
kCCD monolayers were stimulated with 1 nM
dDAVP (96 h, basolateral medium) and sub-
sequently treated with dDAVP only (dDAVP)
or together with 100 M ATP on both the
apical and basolateral sides (dDAVPATP),
the apical side only (dDAVPATP [apical]), or
the basolateral side only (dDAVPATP [baso-
lateral]), for 2 h. Cells were then subjected to
a cell surface biotinylation assay. Biotinylated
proteins were pulled down and immunoblot-
ted for AQP2 (Gly-AQP2 and AQP2). Total
lysates were also immunoblotted for AQP2
(Total AQP2). (C) The signals from B were scanned and the amount of AQP2 was semiquantified in arbitrary units (AU). Significant
differences from untreated cells are indicated by asterisks. The inhibitory effects of apical and basolateral ATP on AQP2 surface
abundance were additive. (D) The signals from an experiment similar to that described in B, except that 100 M ATP, 100 M UTP or
100 M 2meSADP was present on the apical side for 2 h, were scanned and the amount of AQP2 was semiquantified in AU. Significant
differences from untreated cells are indicated by asterisks. Biotinylation experiments were performed in triplicates in two independent
experiments.
Figure 4. Effect of dDAVP on localization of
P2R in mpkCCD cells. Confocal microscopy
was used to determine the cellular distribu-
tion of P2R in monolayers of mpkCCD cells
grown to confluence on transwell permeable
supports. Images shown are x-z planes.
Monolayers were imaged in the x-z plane
from apical to basal boundaries of the cells.
Scale bar represents 5 m. (A) In cells un-
treated with dDAVP, positive immunostaining
(Cy3) for P2X2 receptor subunits and P2Y2 receptors was found throughout the cytoplasm up to the cell border. (B) Treatment of cells
with dDAVP (1 nM, applied to the basolateral medium for 96 h) resulted in positive immunostaining (Cy3) for P2X1 and P2X2 subunits
in the apical domain, and for P2Y2 receptors in the basolateral domain. Not shown, staining for P2X3 and P2X6 subunits, and P2Y6
receptors, was still not seen in the presence of dDAVP; dDAVP treatment also did not alter the positive immunostaining for P2Y1 or P2Y4
receptors in the apical domain, or affect the pattern of immunostaining for P2X4, P2X5 or P2X7 subunits, or P2Y11 or P2Y12 receptors
throughout the cytoplasm (as seen in Figure 3).
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protein levels to a similar degree as that seen for ATP (data not
shown). These findings suggest that adenosine is unlikely to be
responsible for the reduction in AQP2 membrane abundance
observed with ATP.
Effect of P2R Activation on AQP2-Mediated Water
Permeability in Xenopus Oocytes
Tohelp determinewhich of the P2R localized inmpkCCDcells
could mediate the observed downregulation of AQP2 abun-
dance, the P2R localized in the plasmamembrane ofmpkCCD
cells with or without dDAVP (and a number of others) were
co-expressed with AQP2 in Xenopus oocytes, and the oocytes
subjected to a cell swelling assaywith orwithout P2R activation
with 10 MATP.
AQP2-mediated water permeability (Pf) was significantly
decreased following P2R activation in oocytes co-expressing
P2X2 (by 46 8%; n 6; P 0.01; Figure 7A), P2Y2 (by 53
7%; n 6;P 0.01; Figure 7B) or P2Y4 receptors (by 57 3%;
n  6; P  0.01; Figure 7B). Inhibition of AQP2-mediated Pf
was achieved within 15 min. All other P2R tested, including
P2X1, did not change AQP2-mediated Pf (n  6; Figure 7, A
and B).
Todetermine if the reduction ofAQP2-mediatedwater per-
meability by P2R activation also reduced plasma membrane
AQP2 abundance, total membrane and plasma membrane
fractions were made. Immunoblot analysis demonstrated that
in Xenopus oocytes expressing only AQP2 (Figure 8A), or
AQP2 co-expressed with P2X1, P2X3, or P2X4 receptors, extra-
cellular ATP did not alter AQP2 membrane abundance (data
not shown). In contrast, in oocytes expressing those P2R that
reduced AQP2-mediated water permeability on exposure to
ATP (P2X2, P2Y2, and P2Y4), plasmamembrane abundance of
Figure 6. Effect of extracellular ATP on AQP2 protein levels in
mpkCCD cells. (A) Confluent monolayers of mpkCCD cells were
stimulated with 1 nM dDAVP for 4 d, subsequently treated with
dDAVP only or together with 100 M ATP for 8 h, and subjected
to immunoblotting for AQP2. (B) The signals from A were scanned
and the amount of AQP2 was semiquantified in AU. A significant
difference in relative AQP2 abundance between untreated and
treated cells is indicated by an asterisk. (C) As in A, except cells
were left untreated or treated with 100 M ATP and 10 M
DPCPX (an adenosine receptor antagonist) for 8 h. (D) The signals
from C were scanned and the amount of AQP2 was semiquanti-
fied in AU. The asterisk indicates a significant difference. Immu-
noblotting experiments were performed in duplicates in two in-
dependent experiments.
Figure 7. Effect of P2R activation on AQP2-mediated water
permeability in Xenopus oocytes. Comparison of osmotic water
permeability (Pf) in Xenopus oocytes co-expressing AQP2 and the
P2R of interest, in the absence or presence of 10 M ATP (15 min
preincubation). Pf was determined from monitoring and measur-
ing cell swelling (at 1.7 s intervals for 1 min) after cells were placed
in a hypotonic solution. Significant differences from untreated
cells are indicated by asterisks. (A) Activation of co-expressed
P2X2 receptors by extracellular ATP resulted in a significant de-
crease in Pf (n  6; P  0.01). (B) Activation of co-expressed P2Y2
or P2Y4 receptors also resulted in significant decreases in Pf (n 
6; P  0.01). These data show that activation of P2X2, P2Y2, or
P2Y4 subtypes inhibits AQP2 activity within 15 min.
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AQP2 was reduced. This is consistent with P2R-mediated in-
hibition of Pf by P2X2, P2Y2, and P2Y4 receptors by removal of
AQP2 protein from the plasma membrane (n 3; Figure 8B).
DISCUSSION
The main findings of our in vitro study in mpkCCD cells are
that AVP can alter P2R abundance and localization, and that
activation of apically (and basolaterally) localized P2R can
cause the internalization (and degradation) of AQP2 (Figure
9). More specifically, we report that: (1) P2Y1 and P2Y4 recep-
tors are localized in the apical membrane, independent of the
presence of dDAVP; (2) AVP induces cAMP-dependent syn-
thesis and apical localization of AQP2, and of the P2X1 recep-
tor; (3) AVP induces cAMP-dependent translocation and sub-
sequent localization of P2X2 and P2Y2 receptors in the apical
and basolateral membrane, respectively; (4) activation of ba-
solaterally localized P2Y2 receptors, and of apically localized
P2X2 and P2Y4 receptors, stimulates AQP2 internalization in
the presence of AVP. These findings suggest a complex regula-
tory relationship between apical and basolateral P2R in AVP-
stimulated, AQP2-mediated water transport in the CD.
Figure 8. Activation of P2X2, P2Y2, or P2Y4 receptors decreases
plasma membrane abundance of AQP2 in Xenopus oocytes. Typ-
ical Western blot analysis of AQP2 protein in oocyte plasma
membrane homogenates. (A) Oocytes expressing AQP2 in the
absence (lane 1) or presence of 10 M ATP (15 min; lane 2). The
data show that extracellular ATP in the absence of P2R expression
does not directly affect AQP2 membrane abundance. (B) Oocytes
co-expressing AQP2 with P2X2 in the absence (lane 1) or pres-
ence of 10 M ATP (15 min; lane 2); co-expressing AQP2 with
P2Y2 in the absence (lane 3) or presence of 10 M ATP (15 min;
lane 4); and co-expressing AQP2 with P2Y4 in the absence (lane 5)
or presence of 10 M ATP (15 min; lane 6). The data show that P2
receptor-mediated inhibition of cell swelling in Xenopus oocytes
is associated with removal of AQP2 protein from the oocyte
plasma membrane within 15 min.
Figure 9. Vasopressin alters P2R abundance and localization,
and P2R activation results in the internalisation of AQP2. (A)
Immunocytochemistry and patch clamp electrophysiology dem-
onstrate that P2Y1 and P2Y4 receptors are localized in the apical
membrane of mpkCCD cells. (B) Treatment with dDAVP (acting
via basolateral V2 receptors) results in the translocation of P2X2 to
the apical membrane, P2Y2 to the basolateral membrane, and the
synthesis and sorting (or trafficking) of P2X1 and AQP2 to the
apical membrane. (C) Addition of ATP to either the basal or apical
side causes AQP2 to be internalized in mpkCCD cells. Experi-
ments using a Xenopus oocyte swelling assay suggest that the
effects of ATP are mediated via P2Y2, P2Y4, and P2X2 activation.
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P2R Abundance and Localization in mpkCCD Cells
As already mentioned, in cells untreated with AVP, we dem-
onstrated localization of P2Y1 and P2Y4 receptors in the apical
membrane (corroborated by pharmacologic characterization);
and of P2X2, P2X4, P2X5, and P2X7 subunits and P2Y2, P2Y11,
and P2Y12 receptors throughout the cytoplasm. In cells treated
with AVP, in which AQP2 is localized in the apical membrane,
we demonstrated apical localization of P2X1 and P2X2 sub-
units, and of P2Y1 and P2Y4 receptors, and basolateral local-
ization of P2Y2 receptors; while P2X4, P2X5, andP2X7 subunits
and P2Y11 and P2Y12 receptors remained within the cyto-
plasm. Furthermore, using real-time PCR, we showed that
AVP treatment increases mRNA levels of apically localized
P2X1 and basolaterally localized P2Y2 receptors (Figure 2).
Taken together, these data suggest that AVP induces not only
AQP2 translocation and abundance, but also P2X1 subunit and
P2Y2 receptor synthesis and membrane trafficking, and P2X2
subunit membrane trafficking.
Our immunocytochemistry findings of P2R localization in
mpkCCD cells agree broadly with previous reports of the pres-
ence of P2X1, P2X2, P2X3, P2X4, P2X5, and P2X6 subunits and
P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, and P2Y13 receptors in rodent
CD PCs.12,24,35–39 Although others have not reported P2Y1 re-
ceptor protein localization in the CD or in other PC-like cells
in culture, P2Y1 mRNA has been detected in rat CD.40
In contrast to our findings that chronic dDAVP treatment
(96 h) causes an increase in P2Y2 mRNA (Figure 2) and trans-
location of P2Y2 receptors into the basolateralmembrane (Fig-
ure 4), Sun and colleagues reported that chronic dDAVP infu-
sion (120 h) in rats decreases P2Y2 protein levels in the inner
medullary CD.28 The same group also reported that chronic
water loading (48 h), which should lower endogenous AVP
levels, increases P2Y2 abundance.27 In these in vivo studies, as
acknowledged by the authors, the changes in P2Y2 abundance
could have been due to either a direct effect of AVP or changes
in medullary tonicity. Given our findings, the latter seems a
more likely explanation: an increase in tonicity causing sup-
pression, and a decrease causing enhancement, of P2Y2 abun-
dance.
In addition to finding that chronic AVP treatment alters
P2Y2 abundance and localization in mpkCCD cells, we also
found changes in the synthesis and apical localization of P2X1
receptors, and the translocation and subsequent apical local-
ization of P2X2 receptors.We have shown recently that protein
localization and mRNA levels of P2R in the rat CD can be
affected by changes in dietary Na intake.24 We found that
P2X1, P2X4 and P2X6 subunits, and P2Y4 receptors, were up-
regulated by a low Na diet, an effect we attributed to in-
creased circulating aldosterone levels. Activation of the api-
cally localized P2Y4 receptor inhibits the CD epithelial Na

channel (ENaC), whereas the apical P2X4 subunit can inhibit
or stimulate this channel. For the apical P2Y4 receptor at least,
this suggests the possibility of a coupling between its inhibitory
effect on Na and water transport in the CD. Interestingly,
Schafer and Chen have reported that in Na-depleted rats the
stimulatory effect of AVP on Na and water transport in the
CD is significantly reduced.41
P2R-mediated Internalization of AQP2
Until recently, most attention in the CD has focused on P2Y2
receptors, reinforced by recent studies of a P2Y2 knockout
mouse,31 and it has already been established that activation of
basolaterally localized P2Y2 receptors by extracellular nucleo-
tides can inhibit AQP2-mediated water transport in the
CD.12–15 This inhibition of AVP-stimulated, AQP2-mediated
water transport is PLC- and PKC-dependent, and results in
decreased intracellular cAMP and increased PGE2,12,13,15,42
which is known to cause AQP2 internalization.43
The novel data provided by the present study are the effects
of activating apically localized P2R, including P2X subtypes,
on AQP2 trafficking. Although a previous investigation has
reported that stimulation of apical P2Y2 receptors in the ter-
minal segment of the inner medullary CD is without signifi-
cant effect on AQP2-mediated water reabsorption,15 an effect
by other apical P2R subtypes was not excluded in that study.
Here we report that activation of apically localized P2X2 and
P2Y4 receptors, rather than apical P2Y2, stimulates AQP2 in-
ternalization in a cell line derived from the cortical CD, the
region of the CD in which most AVP-stimulated water reab-
sorption occurs. It is likely that the signal transduction path-
way for P2Y4-mediated inhibition of AVP-sensitive water re-
absorption is similar to that for P2Y2 and is Gq protein-
coupled.However, fromour recent study of apical P2R control
of Na transport, we know that P2X signal transduction in-
volves stimulation of PI3K,24 which when activated has also
been shown to stimulate retrieval of AQP2 from the apical
membrane.44
Physiologic Significance
Trying to establish a physiologic role for paracrine or autocrine
regulators of AVP-sensitive water transport is not easy and
risks unwarranted speculation. While there are obvious limi-
tations to both in vitro and in vivo models when it comes to
manipulating the levels and action of AVP, even knockout
mice have so far served only to illustrate how much complex
interaction and compensation can occur in the local and intra-
cellular control of AVP-dependent water permeability in the
CD.42 However, there are at least two obvious questions to ask:
(1) Where does the ATP come from in the CD and how is it
released? (2)Why should there be apical as well as basolateral
control by P2R? Concerning the source and release of ATP, it is
generally believed that ATP is released locally, and that the
stimulus to release may be cell swelling or shear stress, includ-
ing flow-triggered release via the PC apical membrane cili-
um.42,45 Cell swelling under local and more generalized hypo-
tonic conditions, for example, in hyponatremia, could lead to
ATP release, which would then help to maximize water excre-
tion by its action on basolateral P2Y2 receptors and apical P2R.
Similarly, the water diuresis in this setting could further stim-
ulate flow-dependent ATP release to increase water loss.
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In summary, while acknowledging that the present findings
are from an in vitromodel, we have confirmed the location and
function of the basolateral P2Y2 receptor in mediating ATP
inhibition of AVP-dependent water transport along the CD,
but in addition, as with Na transport, we have defined novel
P2R-mediated inhibition of AVP-dependent water transport
through apically located P2R. This apical regulation involves
P2X2 subunits and P2Y4 (rather than P2Y2) receptors; in addi-
tion, AVP itself increases the abundance and membrane traf-
ficking of these inhibitory P2R.
CONCISE METHODS
Cell Culture
mpkCCD cells (clone 14) were grown in a modified cell me-
dium (DMEM:Ham’s F12 1:1 vol/vol; 60 nM sodium selenate,
5 g/ml transferrin, 2 mM glutamine, 50 nM dexamethasone,
1 nM triiodothyronine, 10 ng/ml EGF, 5g/ml insulin, 20mM
D-glucose, 2%FCS, and 20mMHEPES [pH 7.4]).33 Cells were
seeded at a density of 1.5  105 cells/cm2 on semipermeable
filters (Transwell®, 0.4 m pore size, Corning Costar, Cam-
bridge, USA); 1.13 cm2 filters were used for immunocyto-
chemistry or immunoblotting, and 4.7 cm2 filters for biotiny-
lation experiments. The cells remained in culture for 8 d before
being analyzed. Where stated, cells were treated with 1 nM
dDAVP (added to the basolateral medium) for the last 4 d to
induce AQP2 expression maximally (75 to 85% of mpkCCD
cells expressed AQP2 after dDAVP treatment),32 and the nu-
cleotide compounds ATPS, ATP or UTP, or the PKA inhibi-
tor H-89, were applied to the basal and/or apical medium for
the final 2 h. In some cases, DPCPX (and ATPS) was applied
to the basal and apical medium for the final 8 h.
Real-Time PCR
RNA was extracted from confluent monolayers of mpkCCD
cells using an adapted guanidium thiocyanate-phenol-chloro-
form method. One microgram of total RNA was reverse tran-
scribedwith 0.5g oligo(-dt) 12 to 18 primer and a first-strand
cDNA synthesis kit (Superscript II RNaseH- reverse transcrip-
tase, Life Technologies BRL, UK). The resulting cDNA tran-
scripts were used for PCR amplification using a Roche Light-
cycler (Roche diagnostics, Germany) and QuantiTect SYBR®
Green PCR kit (Qiagen,West SussexUK). Gene-specific prim-
ers for P2R and the constitutively expressed gene hypoxan-
thine phosphoribosyl transferase (HPRT) were used as de-
scribed previously.24
To quantify mRNA expression, standard curves were gen-
erated with known amounts of each PCR product. PCR prod-
ucts for each gene were separated on 2% (w/v) agarose-TAE
(Tris-acetate EDTA) gel containing 0.5 g/ml ethidium bro-
mide (Sigma-Aldrich Co., Ltd., Poole, UK). PCR bands were
observed under ultraviolet illumination, excised from the gel
and purified using a Geneclean kit (Qbiogene, Cambridge,
UK).
Purified DNA was serially diluted 10-fold, covering a dy-
namic range of 6 logarithmic orders, and 1l of each standard
was amplified by PCR using the relevant gene specific primers.
One set of P2R standards was amplified in duplicate with the
HPRT standards to generate two standard curves. For each
sample, a ratio of relative abundance of each gene to the house-
keeping gene HPRT was calculated by the Lightcycler Relative
Quantification software, Version 1.0 (Roche Diagnostics, Ger-
many). Melting curve analysis was carried out to determine
primer specificity. PCR products were also analyzed by gel
electrophoresis and visualized using a Bio-Rad multi-imager
(Bio-Rad, Hemel Hempstead, UK).
Immunocytochemistry
Immunocytochemistry and confocal laser scanning microscopy of
cells grown on semipermeable filters were performed as described
previously.46 Cells were incubated with affinity-purified rabbit anti-
AQP2 antibodies or rabbit anti-P2R antibodies.24,47 Noncommercial
P2X antibodies were previously demonstrated to show subunit spec-
ificity.48
Patch Clamp Electrophysiology
Patch clamp electrophysiology of cells grown on glass coverslips was
performed as described previously.24 The whole-cell configuration
was used; this was achieved using a nystatin perforated-patchmethod.
To establish the perforated-patch, nystatin (50 to 100 g/ml) was
added to the pipette solution (50mMKCl, 90mMK-gluconate, 3mM
MgCl2, 3 mM EGTA and 10 mM Hepes [pH 7.2, KOH]). Patch pi-
pettes were pulled from borosilicate glass capillaries (Harvard Appa-
ratus Ltd, Edenbridge, UK) and had a resistance ranging between 4.0
and 6.0 M.
Cells were superfused (4 ml/min) with bathing solution (140 mM
NaCl, 5 mM KCl, 2 mM CaCl2, 1 mMMgCl2 and 10 mMHepes [pH
7.4, NaOH]) by a gravity-fed, continuous flow system that allowed
drug addition and washout. P2R agonist-activated membrane cur-
rents were recorded at a holding potential (Vh) of60 mV, sufficient
to drive P2X-mediated inward cationic currents and P2Y-mediated
reporter currents. P2R agonists were applied for 60 s or until the
current reached a peak, whichever was longer, then washed out for 3
min to avoid run-down.
Water Permeability (Pf) Measurements
Xenopus laevis oocytes were obtained and defolliculated as described
previously.49 Defolliculated oocytes were injected with 50 nl of sterile
water, or cRNA/cRNA combination (50% P2R/50% AQP2) in the
case of co-expression studies (total cRNA quantities: human AQP2,
0.5 ng; rat P2X1,P2X3, P2X6, P2Y1, P2Y2, P2Y4 and P2Y6, 50 ng; rat
P2X2 and P2X7, 20 ng). Injected oocytes were incubated for 48 h at 18
°C in Barth’s solution (88 mM NaCl, 1 mM KCl, 0.82 mM MgSO4,
0.33 mM Ca(NO3)2, 2.4 mM NaHCO3, 0.41 mM CaCl2, and 10 mM
Hepes [pH 7.4]) and was supplemented with 50 g/L gentamicin
sulfate, then kept at 4 °C until used in experiments. Recombinant
cRNA was not available for P2Y6, P2Y11, or P2Y12 receptors.
Oocytes were analyzed after 48 h in a swelling assay as described
previously.7 Oocyte swelling was performed at 22 °C after transfer
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from 200 to 70 mOsM/kg. Where stated, oocytes were preincubated
with ATP (10 M) for 15 min before the swelling assay started.
Immunoblotting
Immunoblotting and biotinylation experiments were performed as
described previously.5,7 Affinity-purified rabbit anti-AQP2 antibod-
ies (1:3000)47 or mouse anti--actin (Sigma, St. Louis, MO; 1:25.000)
primary antibodies were used. As secondary antibodies, goat anti-
rabbit or sheep anti-mouse antibodies coupled to horseradish perox-
idase (HRP; Sigma, St. Louis, MO; 1:10,000) were used. Films were
scanned using a GS-690 Imaging Densitometer (Bio-Rad, Hercules,
CA) and analyzed using Bio-Rad software.
Statistical Analysis
All data are presented as mean values S.E.M.; significance was eval-
uated by t test (Instat v3.0: GraphPad Software, San Diego, CA), with
P 0.05 considered significant. Each experimentwas repeated at least
three times.
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